| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 170,204 | 151,761 | 96,608 | 135,796 | | Cost of Revenue | (2,055) | 39,891 | 38,770 | 52,834 | | | Gross Profit | 172,259 | 111,870 | 57,838 | 82,962 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 40,878 | 9,351 | 10,284 | 7,907 | | Non Recurring | 21,738 | 23,190 | 35,289 | 10,739 | | Others | 51,030 | 53,148 | 50,697 | 53,074 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 59,286 | 26,181 | (38,432) | 11,242 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (348) | 301 | 147 | 663 | | Earnings Before Interest And Taxes | 59,480 | 26,482 | (38,285) | 11,905 | | Interest Expense | 4,763 | 4,723 | 4,587 | 3,406 | | Income Before Tax | 54,717 | 21,759 | (42,872) | 8,499 | | Income Tax Expense | 19,788 | 8,251 | (16,259) | 8,083 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 34,929 | 13,508 | (26,613) | 416 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,929 | 13,508 | (26,613) | 416 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,929 | $13,508 | ($26,613) | $416 |
|
0.51% Nasdaq 
Income Statement
